PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Zi Diligence Biocenter, Bioequivalence Research, El-Mokattam, Cairo, Egypt.\', \'Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt.\', \'Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Kafr El-Sheikh University, Kafr El-Sheikh City, Egypt; Mass Spectrometry Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 N. Pine Street, Baltimore, MD 21201, USA. Electronic address: ahmed.ali@rx.umaryland.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0731-7085(21)00168-010.1016/j.jpba.2021.114057
?:doi
?:hasPublicationType
?:journal
  • Journal of pharmaceutical and biomedical analysis
is ?:pmid of
?:pmid
?:pmid
  • 33831737
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.919
?:rankingScore_hIndex
  • 108
?:title
  • A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all